1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CTDSP2 CTRPv2 pan-cancer AAC -0.082 0.03
mRNA CLIP1 CTRPv2 pan-cancer AAC -0.092 0.03
mRNA CCL25 CTRPv2 pan-cancer AAC 0.08 0.03
mRNA YWHAG CTRPv2 pan-cancer AAC 0.084 0.03
mRNA TNS1 CTRPv2 pan-cancer AAC -0.089 0.03
mRNA NOV CTRPv2 pan-cancer AAC -0.079 0.03
mRNA CTF1 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA FLVCR1 CTRPv2 pan-cancer AAC 0.089 0.03
mRNA MRM3 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA OR2A25 CTRPv2 pan-cancer AAC -0.081 0.03
Download CSV